关于脏酸盐运输的最新信息
Carsten Alexande Wagner1, Daniela Egli-Spichtig, Isabel Rubio-Aliaga
1Institute of Physiology and Zurich Kidney Center, University of Zurich, Zurich, Switzerland.
Current opinion in nephrology and hypertension
|May 13, 2025
概括
脏通过NaPi载体调节酸盐平衡. 讨论了对它们的调节,遗传学和作为高酸血症和脏疾病的药物点潜力的新见解.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 脏通过无机酸盐 (Pi) 的再吸收来维持全身酸盐平衡.
- 靠近管状细胞表达了三个关键的Na+驱动的Pi配运输体:NaPi-IIa (SLC34A1),NaPi-IIc (SLC34A3) 和PiT-2 (SLC20A2).这些配运输体主要由Na+驱动.
研究的目的:
- 审查脏酸盐输送器调节,药理学和遗传学的新方面.
- 探索针对这些传送器的治疗潜力.
主要方法:
- 关于脏酸盐输送器的当前文献的综述.
- 对遗传变异及其临床表现的分析.
- 关于药理干预的讨论.
主要成果:
- 脏NaPi输送器受PTH和FGF23等激素,以及潜在的IP6激酶的调节.
- 在CKD模型中,NaPi载体的抑制剂会诱导酸化,并可能降低CKD模型中的PTH和FGF23.
- 在SLC34载体中失去功能的突变与骨瘤,恶心病和加速功能下降有关.
结论:
- 脏Pi输送器是动态调节的,代表潜在的治疗点.
- 准这些载体可能为管理高酸血症提供新的策略.
- 脏Pi载体中的遗传变异有助于结石的形成和慢性病 (CKD) 风险.
相关概念视频
Renal Drug Excretion: Tubular Secretion
91
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
91
Drug Elimination by Renal Route: Tubular Secretion
2.1K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.1K
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
112
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
The pKa of a...
112
Renal Drug Excretion: Tubular Reabsorption
61
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
61
Roles of Electrolytes: Calcium and Phosphate
107
Calcium and phosphate are essential electrolytes in the human body, with calcium being the most abundant mineral. Around 99% of the body's calcium is stored in the skeleton and teeth, forming a crystal lattice of mineral salts in combination with phosphates. Calcium plays crucial roles in various bodily functions such as blood clotting, neurotransmitter release, muscle tone maintenance, and nervous and muscle tissue excitability.
The calcium concentration in blood plasma is primarily...
The calcium concentration in blood plasma is primarily...
107
Renal Failure: Dose Adjustments
37
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
37


